Skip to main navigation Skip to search Skip to main content

Myeloid neoplasms arising after methotrexate therapy for autoimmune rheumatological diseases do not exhibit poor-risk molecular features

  • Mihir D. Wechalekar
  • , Lin Pierre Zhao
  • , Monika M. Kutyna
  • , Lih En Hong
  • , Joule Li
  • , Kevin Hung
  • , Hamish S. Scott
  • , Anna Brown
  • , Christopher C. Hahn
  • , Karin Kassahn
  • , Dariusz Ladon
  • , David T. Yeung
  • , Daniel Thomas
  • , Mrinal Patnaik
  • , Susanna Proudman
  • , Lionel Ades
  • , Mithun V. Shah
  • , Chung H. Kok
  • , Devendra K. Hiwase

Research output: Contribution to journal › Letter › peer-review

13 Downloads (Pure)
Original languageEnglish
Article number116
JournalBlood Cancer Journal
Volume14
Issue number1
DOIs
Publication statusPublished or Issued - Dec 2024
Externally publishedYes

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this